Relative prognostic value of baseline q wave and time from symptom onset among men and women with ST-elevation myocardial infarction undergoing percutaneous coronary intervention

American Journal of Cardiology

Volumn 110, Issue 11, 2012, Pages 1555-1560

  Kaul, Padma ^a   Fu, Yuling ^a   Westerhout, Cynthia M ^a   Granger, Christopher B ^b   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PEXELIZUMAB; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CLASSIFICATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE CLEARANCE; DEATH; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAM; FEMALE; GROUPS BY AGE; HUMAN; HYPERTENSION; KILLIP CLASSIFICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; RISK ASSESSMENT; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TIME; TIME FROM SYMPTOM ONSET; TREATMENT OUTCOME;

AGED; ALBERTA; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL, HUMANIZED; CONFIDENCE INTERVALS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORTH CAROLINA; PROGNOSIS; PROSPECTIVE STUDIES; SINGLE-CHAIN ANTIBODIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84869094877     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.07.020     Document Type: Article

References (13)

1. J.C. McSweeney, M. Cody, P. O'Sullivan, K. Elberson, D.K. Moser, B.J. Garvin Women's early warning symptoms of acute myocardial infarction Circulation 108 2003 2619 2623
2. M.M. Graham, C.M. Westerhout, P. Kaul, C.M. Norris, P.W. Armstrong Sex differences in patients seeking medical attention for prodromal symptoms before an acute coronary event Am Heart J 156 2008 1210 1211
3. M.J. Eskola, L. Holmvang, K.C. Nikus, S. Sclarovsky, H.H. Tilsted, H. Huhtala, K.O. Niemelä, P. Clemmensen The electrocardiographic window of opportunity to treat vs. the different evolving stages of ST-elevation myocardial infarction: correlation with therapeutic approach, coronary anatomy, and outcome in the DANAMI-2 trial Eur Heart J 28 2007 2985 2991
4. C.-K. Wong, W. Gao, O.C. Raffel, J.K. French, R.A. Stewart, H.D. White HERO-2 Investigators Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2 Lancet 367 2006 2061 2067
5. P.W. Armstrong, Y. Fu, C.M. Westerhout, M.P. Hudson, K.W. Mahaffey, H.D. White, T.G. Todaro, P.X. Adams, P.E. Aylward, C.B. Granger Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention J Am Coll Cardiol 53 2009 1503 1509
6. H. Siha, D. Das, Y. Fu, Y. Zheng, C.M. Westerhout, R.F. Storey, S. James, L. Wallentin, P.W. Armstrong Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial CMAJ 184 2012 1135 1142
7. APEX AMI Investigators Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial JAMA 297 2007 43 51
8. W.D. Anderson, N.B. Wagner, K.L. Lee, R.D. White, J. Yuschak, V.S. Behar, R.H. Selvester, R.E. Ideker, G.S. Wagner Evaluation of a QRS scoring system for estimating myocardial infarct size VI: Identification of screening criteria for non-acute myocardial infarcts Am J Cardiol 61 1988 729 733
9. E.M. Antman, D.T. Anbe, P.W. Armstrong, E.R. Bates, L.A. Green, M. Hand, J.S. Hochman, H.M. Krumholz, F.G. Kushner, G.A. Lamas, C.J. Mullany, J.P. Ornato, D.L. Pearle, M.A. Sloan, S.C. Smith Jr, J.S. Alpert, J.L. Anderson, D.P. Faxon, V. Fuster, R.J. Gibbons, G. Gregoratos, J.L. Halperin, L.F. Hiratzka, S.A. Hunt, A.K. Jacobs, J.P. Ornato ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) J Am Coll Cardiol 44 suppl 2004 E1 E211
10. A. Stebbins, R.H. Mehta, P.W. Armstrong, K.L. Lee, C. Hamm, F. Van de Werf, S. James, T. Toftegaard-Nielsen, R. Seabra-Gomes, H.D. White, C.B. Granger Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI Investigators) A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial Circ Cardiovasc Interv 3 2010 414 422
11. J.G. Canto, W.J. Rogers, R.J. Goldberg, E.D. Peterson, N.K. Wenger, V. Vaccarino, C.I. Kiefe, P.D. Frederick, G. Sopko, Z.J. Zheng NRMI Investigators Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality JAMA 307 2012 813 822
12. P. Kaul, P.W. Armstrong, S. Sookram, B.K. Leung, N. Brass, R.C. Welsh Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction Am Heart J 161 2011 91 97
13. J. Mehilli, A. Kastrati, J. Dirschinger, J. Pache, M. Seyfarth, R. Blasini, D. Hall, F.J. Neumann, A. Schömig Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention JAMA 287 2002 210 215